PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 203 filers reported holding PDL BIOPHARMA INC in Q2 2016. The put-call ratio across all filers is 2.73 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $5,000 | – | 1,562 | 0.0% | 0.00% | – |
| Q4 2021 | $0 | – | 1,562 | 0.0% | 0.00% | – |
| Q3 2021 | $0 | – | 1,562 | 0.0% | 0.00% | – |
| Q2 2021 | $0 | – | 1,562 | +2197.1% | 0.00% | – |
| Q1 2021 | $0 | – | 68 | 0.0% | 0.00% | – |
| Q4 2020 | $0 | – | 68 | -41.4% | 0.00% | – |
| Q3 2020 | $0 | -100.0% | 116 | -79.1% | 0.00% | – |
| Q3 2017 | $2,000 | +100.0% | 555 | 0.0% | 0.00% | – |
| Q2 2017 | $1,000 | 0.0% | 555 | 0.0% | 0.00% | – |
| Q1 2017 | $1,000 | 0.0% | 555 | 0.0% | 0.00% | – |
| Q4 2016 | $1,000 | -50.0% | 555 | 0.0% | 0.00% | – |
| Q3 2016 | $2,000 | -60.0% | 555 | -64.9% | 0.00% | – |
| Q2 2016 | $5,000 | 0.0% | 1,581 | +1.9% | 0.00% | – |
| Q4 2015 | $5,000 | – | 1,551 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KESTREL INVESTMENT MANAGEMENT CORP | 1,465,000 | $3,853,000 | 1.56% |
| SMH CAPITAL ADVISORS INC | 93,708 | $246,000 | 0.42% |
| West Family Investments, Inc. | 627,800 | $1,651,000 | 0.39% |
| KENNEDY CAPITAL MANAGEMENT LLC | 7,082,858 | $18,628,000 | 0.35% |
| ARMISTICE CAPITAL, LLC | 1,800,000 | $4,734,000 | 0.28% |
| BRANDES INVESTMENT PARTNERS, LP | 3,936,719 | $10,354,000 | 0.23% |
| ROCKY MOUNTAIN ADVISERS, LLC | 14,300 | $38,000 | 0.13% |
| Zebra Capital Management LLC | 74,695 | $196,000 | 0.09% |
| Connor, Clark & Lunn Investment Management Ltd. | 5,968,105 | $15,696,000 | 0.09% |
| CREDIT AGRICOLE S A | 471,644 | $1,240,000 | 0.06% |